May 2015
In its first cooperative venture with a professor at an Israeli university, Pfizer has announced that it will be collaborating with BIU Prof. Ido Bachelet on his research project that will enable DNA robots to deliver medical proteins to designated tissue.
Read more »
May 2015
A “trio” of proteins that appear to play a pivotal role in the onset of various cancers has been revealed by Uri Nir, Director of the Nano Medicine Center at the Institute of Nanotechnology and Advanced Materials at Bar-Ilan. Nir is now proceeding to develop novel anti-cancer drugs that will target key regulators.
Read more »
March 2015
When it comes to cancer of the breast, there’s a problem: the initial diagnosis sometimes marks the beginning of a long process, in which doctors struggle to identify the best therapeutic approach.
Read more »
March 2015
Dr. Michael Blank’s father’s death set him on a career path to be part of a research team that discovered a tumor suppressor gene called Smurf2, and now pursue his quest to understand the origin of cancer cells as assistant professor and senior lecturer at the Bar-Ilan University (BIU) Medical School in Safed.
Read more »
January 2015
Dr. Meir Shamay is focusing on uncovering the mechanism of cancer development caused by transmitted viruses, at his lab at the Bar-Ilan University Medical School in Safed.
Read more »
November 2014
As we age, there’s a normal decline of cognitive function, but by age 65, about one sixth of the population exhibits the creeping dementia associated with Alzheimer’s. Dr. Okun and his research team are fighting that trend.
Read more »
October 2014
Using gold particles as a diagnostic tool, Dr. Dror Fixler and his team at the Advanced Light Microscopy Laboratory at BIU have created a non-invasive optical system to detect cancer of the head, neck, tongue and throat. It has proven itself during its first human tests.
Read more »
May 2014
Prof. Zeev Zalevsky, head of the Electro-Optics study program at Bar-Ilan’s Faculty of Engineering, has developed a bionic contact lens that has tremendous potential to enable the blind to see. It processes digital images and translates them into tactile sensations, allowing him or her to form a picture.
Read more »
March 2014
A major highlight of President Shimon Peres’ recent visit to Bar-Ilan was seeing firsthand the cutting-edge research work taking place at the Gonda (Goldschmied) Multidisciplinary Brain Research Center, which has been generously supported by the Gonda Family through a gift to AFBIU.
Read more »
January 2014
The benefit that premature infants gain from skin-to-skin contact with their mothers is measurable even 10 years after birth, according to BIU Prof. Ruth Feldman of the faculty of Bar-Ilan’s Gonda Multidisciplinary Brain Research Center.
Read more »
December 2013
Millions of people get sick from bacterial infections contracted during a hospital stay that in some cases also cause or contribute to over 100,000 preventable deaths a year. That’s something that BIU Prof. Aharon Gedanken aims to eliminate.
Read more »
December 2013
The Mishna of Pirke Avot defines our sixth decade as the point at which we should be honored as “elderly.” But in medical terms, some 15% of people aged 60-plus get more than added respect; the “prevalence of dementia among community-dwelling elderly in Israel is estimated to be about 20%.”
Read more »
August 2013
A new generation of nano-medicines for the treatment of HIV/AIDS, Hepatitis-C and other viral infections is being developed by Vecoy Nanomedicines Ltd., a privately held company based out of the Bar-Ilan Institute of Nanotechnology and Advanced Materials (BINA).
Read more »
